Vivos Therapeutics (VVOS) Share-based Compensation Growth (1y) (2021 - 2026)
Vivos Therapeutics (VVOS) Share-based Compensation Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 9.69% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 37.62% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 6.74% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 12.16% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 12.94% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -30.44% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 59.09% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Vivos Therapeutics | 3.62 Mn | 1.38 Mn | 3.06 Mn | 720.19% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 720.19% |
| Dec 31, 2025 | -14.00% |
| Sep 30, 2025 | 833.33% |
| Jun 30, 2025 | -96.00% |
| Mar 31, 2025 | 8.19% |
| Dec 31, 2024 | 110.95% |
| Sep 30, 2024 | 50.00% |
| Jun 30, 2024 | 1,775.00% |
| Mar 31, 2024 | -4.25% |
| Dec 31, 2023 | -217.81% |
| Sep 30, 2023 | -50.00% |
| Jun 30, 2023 | -42.86% |
| Mar 31, 2023 | -49.75% |
| Dec 31, 2022 | -70.62% |
| Sep 30, 2022 | -63.64% |
| Jun 30, 2022 | 16.67% |
| Mar 31, 2022 | 40.32% |
| Dec 31, 2021 | 65.07% |
| Sep 30, 2021 | 156.61% |
| Jun 30, 2021 | 6.12% |